8-K: Qrons Inc. Completes Merger with First Person Ltd., Creating Publicly Traded Cognitive Wellness Leader

Qrons Inc. finalizes its merger with First Person Ltd., establishing a publicly traded entity focused on cognitive wellness and functional beverages.

Summary

• Qrons Inc. has completed its merger with First Person Ltd. effective January 31, 2025.
• First Person is now a wholly-owned subsidiary of Qrons.
• The combined company will operate under the First Person brand.
• Each share of First Person common stock was converted into the right to receive shares of Qrons Series B Convertible Preferred Stock.
• Qrons intends to change its name to First Person, Inc. and increase the number of authorized common shares to 500,000,000.
• An Anti-Dilution Agreement was entered into to protect certain Qrons shareholders from dilution for 12 months after the 2024 10-K filing.
• Cory Rosenberg has been appointed as the CEO, President, Acting CFO, and Secretary of Qrons, while Chris Claussen has been appointed as the Chief Innovation Officer.
• The company is focused on scaling its cognitive wellness platform, expanding its brand footprint, and driving innovation in cognitive optimizing and alcohol-free social experience products.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the merger is presented positively, the document also acknowledges significant financial challenges and risks associated with the company's limited operating history and need for additional funding. The company is also dependent on consumer perception of mushrooms and mushroom-based products.

Positives

• The merger creates a publicly traded company in the growing cognitive wellness and functional beverage markets.
• First Person has a proprietary ingredient innovation and extraction technology.
• The company has a differentiated consumer product portfolio and brand positioning.
• First Person has direct-to-consumer (DTC) expertise and scalable distribution.
• The company has a mission-driven approach and the ability to execute and scale.
• The company is expanding into the ready-to-drink (RTD) alcohol-free functional beverage market, which may provide a first-to-market advantage.
• The company has a high-margin, subscription-based DTC platform, allowing for direct consumer engagement, data-driven marketing, and scalable customer acquisition.

Negatives

• The company has a limited operating history and a history of net losses.
• The company will need additional financing to continue to sustain operations.
• There is substantial doubt about the company's ability to continue as a going concern.
• The company faces significant ongoing costs and obligations related to developing its business and products.
• The company faces competition in the markets in which it operates.
• The company is dependent on the popularity and consumer acceptance of its brand.
• The company may face unfavorable publicity or consumer perception.
• The company is highly dependent upon consumer perception of mushrooms and mushroom-based products.
• The company may not be successful in developing a marketing and sales force for the commercialization of its products.
• The company may be unable to adequately protect its brand and its other intellectual property rights.

Risks

• The company has a limited operating history and a history of net losses, and may not achieve or maintain profitability in the future.
• The company will need additional financing to continue to sustain operations, and there is no assurance that such financing will be available on favorable terms or at all.
• There is substantial doubt about the company's ability to continue as a going concern.
• The company faces significant ongoing costs and obligations related to developing its business and products, and these costs may increase in the future, which may result in significant losses.
• The company faces competition in the markets in which it operates, and some of its competitors have longer operating histories and may have more financial resources and manufacturing and marketing experience than it has.
• The company may expend substantial time and financial resources on potential acquisitions of other companies and such acquisitions may not be completed or successful.
• The company may not be able to develop as many nutraceutical products of the consistency or quality that it expects, which could have a negative adverse effect on its business plan and profitability.
• The company is dependent on the popularity and consumer acceptance of its brand, and there is no assurance that it will be able to achieve brand awareness in any of its target regions.
• The company may face unfavorable publicity or consumer perception, and its reputation could suffer from real or perceived issues involving the labeling or marketing of its products.
• The company is highly dependent upon consumer perception of mushrooms and mushroom-based products, and the public may associate its fully legal functional mushroom and nutraceutical products with illegal psychedelic mushrooms.
• The company may not be successful in developing a marketing and sales force for the commercialization of its products, or it may incur substantial expenses to do so.
• The company may be unable to adequately protect its brand and its other intellectual property rights.
• The company's internal computer systems may fail or suffer security breaches, which could result in a significant disruption of its product development programs and its ability to operate its business effectively.
• The company's ability to produce and sell its products is dependent on compliance with regulatory and other requirements.
• The company faces inherent and significant risks related to product liability and similar claims.
• The company is highly dependent on its management team, and the loss of any key member of this team may prevent it from implementing its business plan in a timely manner, or at all.
• Adverse U.S. or international economic conditions, including periods of inflation, could negatively affect the company's business, financial condition, and results of operations.

Future Outlook

The combined company will operate under the First Person brand, leveraging its proprietary ingredient formulations, direct-to-consumer success, and omni-channel distribution strategy to drive long-term value for both consumers and shareholders. The company's immediate focus is on scaling its cognitive wellness platform, expanding its brand footprint, and driving innovation in cognitive optimizing and alcohol-free social experience products.

Management Comments

• Consumers are shifting their priorities, seeking smarter ways to enhance mental clarity, stress relief, and social experiences, said Cory Rosenberg, CEO of First Person.
• With this merger, First Person is now in a position to scale efficiently expanding our product line, increasing market reach, and introducing groundbreaking innovations that redefine how people think about cognitive health and social drinking.
• While Qrons was on the path to exciting scientific breakthroughs, our responsibility was to create value for our shareholders, added Jonah Meer, outgoing CEO of Qrons.
• In First Person, we saw a company with the vision, leadership, and innovation to do just that.
• It was a pleasure working with Cory and his team on this merger, and I look forward to watching First Person thrive.

Industry Context

The announcement highlights a move towards cognitive wellness and functional beverages, aligning with growing consumer trends in functional nutrition, alcohol alternatives, and nootropics. The company aims to capitalize on the increasing demand for healthier alternatives to traditional stimulants and alcohol.

Comparison to Industry Standards

• First Person competes with companies like Laird Superfood, Inc. in the cognitive wellness and nootropics market.
• The company's social tonic competes in the rapidly growing RTD alcohol alternatives space, differentiating itself from traditional non-alcoholic options.
• First Person's Crystallized Lions Mane and potential additional future ingredient innovations offer opportunities for expansion into B2B ingredient supply, providing high-potency extracts for third-party food, beverage, and wellness brands.

Management Changes

Stakeholder Impact

• Shareholders of Qrons will see a shift in the company's business focus and management.
• Employees of both Qrons and First Person may experience changes in roles and responsibilities.
• Customers will have access to a broader range of cognitive wellness and functional beverage products.
• Suppliers may see changes in procurement strategies and relationships.
• Creditors will be impacted by the financial performance and stability of the combined entity.

Next Steps

• Change the company name to First Person, Inc.
• Increase the number of authorized shares of common stock to 500,000,000.
• Scale the cognitive wellness platform.
• Expand the brand footprint and market reach.
• Drive innovation in cognitive optimizing and alcohol-free social experience products.
• File the financial statements of First Person Ltd. by an amendment to this Current Report on Form 8-K no later than 71 days following the date that this Current Report is required to be filed.

Key Dates

Keywords

merger, First Person Ltd, Qrons Inc, cognitive wellness, functional beverages, anti-dilution agreement, nutraceuticals, functional mushrooms, Cory Rosenberg, acquisition